Photo of Sushrut S. Waikar,  MD, MPH

Sushrut S. Waikar, MD, MPH

Brigham And Women's Hospital

Brigham And Women's Hospital
Phone: (617) 732-8473
Fax: (617) 732-6392


swaikar@partners.org

Sushrut S. Waikar, MD, MPH

Brigham And Women's Hospital

EDUCATIONAL TITLES

  • Associate Professor, Medicine, Harvard Medical School
  • Associate Physician, Medicine, Brigham And Women's Hospital

DF/HCC PROGRAM AFFILIATION

Research Abstract

Dr. Waikar is a nephrologist at Brigham and Women's Hospital and clinical researcher interested in acute kidney injury and chronic kidney disease. He is particularly interested in novel biomarkers of cisplatin-induced nephrotoxicity. Dr. Waikar is a Principal Investigator of a U01 from NIH-NIDDK (Chronic Kidney Disease Biomarkers Consortium).

Publications

Powered by Harvard Catalyst
  • Nakahira K, Kyung SY, Rogers AJ, Gazourian L, Youn S, Massaro AF, Quintana C, Osorio JC, Wang Z, Zhao Y, Lawler LA, Christie JD, Meyer NJ, Mc Causland FR, Waikar SS, Waxman AB, Chung RT, Bueno R, Rosas IO, Fredenburgh LE, Baron RM, Christiani DC, Hunninghake GM, Choi AM. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med. 2014; 10:e1001577; discussion e1001577. PubMed
  • Waikar SS, Betensky RA, Emerson SC, Bonventre JV. Imperfect gold standards for biomarker evaluation. Clin Trials 2013; 10:696-700. PubMed
  • Zhou S, Leboff MS, Waikar SS, Glowacki J. Vitamin D metabolism and action in human marrow stromal cells: Effects of chronic kidney disease. J Steroid Biochem Mol Biol 2012. PubMed
  • Mizuguchi KA, Mitani A, Waikar SS, Ireland P, Panizales C, Deluke G, Sugarbaker DJ, Bonventre JV, Frendl G. Use of postoperative creatinine to predict sustained kidney injury in patients undergoing mesothelioma surgery. Clin J Am Soc Nephrol 2012; 7:1071-8. PubMed
  • Ferguson MA, Vaidya VS, Waikar SS, Collings FB, Sunderland KE, Gioules CJ, Bonventre JV. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int 2010; 77:708-14. PubMed
  • Waikar SS, Betensky RA, Bonventre JV. Creatinine as the gold standard for kidney injury biomarker studies? Nephrol. Dial. Transplant. 2009; 24:3263-5. PubMed
  • Vaidya VS,Ford GM,Waikar SS,Wang Y,Clement MB,Ramirez V,Glaab WE,Troth SP,Sistare FD,Prozialeck WC,Edwards JR,Bobadilla NA,Mefferd SC,Bonventre JV. A rapid urine test for early detection of kidney injury. Kidney Int 2009; 76:108-14. PubMed
  • Waikar SS,Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 2009; 20:672-9. PubMed
  • Vaidya VS,Waikar SS,Ferguson MA,Collings FB,Sunderland K,Gioules C,Bradwin G,Matsouaka R,Betensky RA,Curhan GC,Bonventre JV. Urinary Biomarkers for Sensitive and Specific Detection of Acute Kidney Injury in Humans. Clin Transl Sci 2009; 1:200-208. PubMed
  • Winkelmayer WC, Waikar SS, Mogun H, Solomon DH. Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury. Am J Med 2008; 121:1092-8. PubMed
  • Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 2008; 3:844-61. PubMed
  • Waikar SS,Bonventre JV. Biomarkers for the diagnosis of acute kidney injury. Nephron Clin Pract 2008; 109:c192-7. PubMed
  • Waikar SS, Bonventre JV. Biomarkers for the diagnosis of acute kidney injury. Curr Opin Nephrol Hypertens 2007; 16:557-64. PubMed
  • Waikar SS, Curhan GC, Ayanian JZ, Chertow GM. Race and mortality after acute renal failure. J Am Soc Nephrol 2007; 18:2740-8. PubMed
  • Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 2006; 17:1143-50. PubMed
Hide